Asia Executives On The Move: BMS, Pfizer, Takeda, RDPAC

Rapid changes in China prompt many pharma companies to shuffle strategies and accelerate personal changes. BMS is getting a new country GM, Pfizer Biopharma China GM is departing and Takeda BU head is stepping down.

Shanghai overpass
MULTINATIONAL DRUG MAKERS SEE MORE EXECUTIVES CHANGES IN CHINA • Source: Shutterstock

Former GSK China executive Siyuan Chen has been appointed as Bristol-Myers Squibb Co.China GM, effective 2 December. Chen was VP and head of respiratory and anti-infectious/HIV business for GlaxoSmithKline PLC China.

Chen succeeds Shirley Zhao who stepped down in June

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Scrip